Information on transaction in Company shares under Article 19 MAR

Current report no. 39/2025 

Date of preparation: 25.09.2025 

Subject: Information on transaction in Company shares under Article 19 MAR 

Legal basis: Article 19(3) MAR - information on transactions carried out by management / closely related persons 

Content of the report: 

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) announces that it has received from Krzysztof Samotij, Member of the Company's Supervisory Board, a notification of a transaction on the Company's shares (conclusion of a share subscription agreement), as referred to in Article 19(1) of the MAR Regulation. 

The share subscription agreement was concluded within the framework of the incentive programme. 

The content of the notification is attached to this report.